+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 68 Pages
  • July 2024
  • Region: Global
  • GlobalData
  • ID: 5996060
The Medical Devices sector report, “Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Metered dose inhaler devices deliver a specific amount of medication to the lungs. A metered-dose inhaler consists of a canister, the metering valve and an actuator.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Metered Dose Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to :

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Metered Dose Inhaler Devices Overview
3 Products under Development
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials
4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
5 Metered Dose Inhaler Devices Companies and Product Overview6 Metered Dose Inhaler Devices- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Metered Dose Inhaler Devices - Pipeline Products by Territory
  • Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  • Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  • Metered Dose Inhaler Devices - Ongoing Clinical Trials
  • Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
  • Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Metered Dose Inhaler Devices - Pipeline Products by Territory
  • Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  • Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  • Metered Dose Inhaler Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aerophase Inc
  • Bloom Labs
  • DMK Pharmaceuticals Corp
  • Globe Medical Tech Inc (Inactive)
  • GSK plc
  • Impulse Biomedical
  • Kindeva Drug Delivery LP
  • Lab Automate Technologies Inc
  • Lupin Pharmaceuticals Inc
  • Medicom Innovation Partner a/s
  • Nemera La Verpilliere
  • Niox Group Plc
  • Pearl Therapeutics Inc
  • Rapid Therapeutic Science Laboratories Inc
  • Reciprocal Labs Corp
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • Syqe Medical Ltd
  • TM Global Bioscience LLC
  • Transpire Bio Inc
  • Verona Pharma Plc